Bulletin
Investor Alert

New York Markets Open in:

Century Therapeutics Inc.

NAS: IPSC

GO
/marketstate/country/us

After Hours

 --Quotes are delayed by 20 min

Jan 31, 2023, 7:10 p.m.

/zigman2/quotes/210490648/composite

$

4.68

Change

+0.11 +2.41%

Volume

Volume 1,727

Quotes are delayed by 20 min

/zigman2/quotes/210490648/composite

Previous close

$ 4.51

$ 4.57

Change

+0.06 +1.33%

Day low

Day high

$4.51

$4.68

Open

52 week low

52 week high

$4.34

$15.38

Open

Insider Actions for Century Therapeutics Inc.

– Purchase – Sale 1 – Number of Transactions
Date Name Shares Transaction Value
08/09/2022 Versant Venture Management LLC
364,800   0
08/09/2022 Versant Venture Management LLC
550,000   Disposition at $13.03 per share. 7,166,500
01/31/2022 Versant Venture Management LLC
178,996   0
12/23/2021 Versant Venture Management LLC
371,004   0
06/22/2021 Bayer AG
750,000   Acquisition at $20 per share. 15,000,000
06/22/2021 Versant Venture Management LLC
100,000   Acquisition at $20 per share. 2,000,000
06/22/2021 Eli Casdin
Director
750,000   Acquisition at $20 per share. 15,000,000
06/22/2021 Bayer AG
1,535,238   Derivative/Non-derivative trans. at $0 per share. 0
06/22/2021 Bayer AG
10,390,600   Derivative/Non-derivative trans. at $0 per share. 0
06/22/2021 Versant Venture Management LLC
614,095   Derivative/Non-derivative trans. at $0 per share. 0
06/22/2021 Versant Venture Management LLC
9,936,011   Derivative/Non-derivative trans. at $0 per share. 0
06/22/2021 FUJIFILM Holdings Corp.
3,974,404   Derivative/Non-derivative trans. at $0 per share. 0
06/22/2021 Eli Casdin
Director
2,456,380   Derivative/Non-derivative trans. at $0 per share. 0

Transaction Summary

Total insider purchases and sales reported to the SEC

Timeframe Transactions Shares
Last 3 months
0 Purchases
0 Sales
0
0
Last 6 months
0 Purchases
2 Sales
0
914,800
Last 12 months
0 Purchases
2 Sales
0
914,800

Officers and Executives

Mr. Joseph Jimenez
Chairman
Dr. Osvaldo Flores
President, Chief Executive Officer & Director
Dr. Adrienne Farid
Chief Operations Officer
Mr. Douglas Carr
Vice President-Finance & Operations
Dr. Hyam I. Levitsky
President-Research & Development
Dr. Luis Borges
Chief Scientific Officer
Dr. Gregory Russotti
Chief Technology Officer
Dr. Mike C. Diem
Chief Business Officer
Mr. Kenneth J. Dow
Head-Legal & Compliance
Dr. Carlo Rizzuto
Director
Dr. Alessandro Riva
Director
Dr. Kimberly L. Blackwell
Director
Dr. Shane N. O. Williams
Chief People Officer
Ms. Cynthia M. Butitta
Independent Director
Ms. Daphne E. Quimi
Independent Director
Mr. Timothy P. Walbert
Independent Director
Link to MarketWatch's Slice.